Alaska Chapter of the American College of Cardiology

Short-term DAPT, PCI & High Bleeding Risk; Dapagliflozin, Non-Pharmacologic Treatment of HF
In this weekâ€™s View, Dr. Eagle looks at a sex-based analysis of short-term dual antiplatelet therapy (DAPT) in patients receiving percutaneous coronary intervention (PCI) who are deemed at high-risk for bleeding.
HCM Research Explores SCD Risk Stratification, High Intensity Exercise, and Benefits of Valsartan
Although the 2024 ACC/American Heart Association (AHA) and 2023 European Society of Cardiology (ESC) guidelines stratify well overall the risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)...
Treatment Algorithm Proposed For Endovascular Treatment of Chronic Femoropopliteal Lesions
A State-of-the-Art Review published March 10 in JACC: Cardiovascular Interventions highlights a proposed treatment algorithm for the endovascular revascularization of femoropopliteal lesions and chronic total occlusions.
Your Guide to Advocacy Sessions and Events at ACC.25
There is no shortage of opportunities to learn more about advocacy topics and engage with the ACC Advocacy team at ACC.25, taking place March 29-31 in Chicago, IL.
Heart Valve Collaboratory Framework For Post-TAVR TVF Imaging
The Heart Valve Collaboratory has proposed a framework to standardize best practices for using multimodality imaging in transcatheter valve failure (TVF) following transcatheter aortic valve replacement (TAVR), in a State-of-the-Art Review...